6th Biomarkers Summit

Organization: SMi Group

Venue: Copthorne Tara Hotel London Kensington

Location: London, United Kingdom

Event Date/Time: Jan 16, 2013 End Date/Time: Jan 17, 2013
Report as Spam


 The drive towards personalized medicine is seeing pharma move from patient stratification as a ‘nice to have’, to an essential feature of product development. Exemplified by the success of Herceptin, biomarkers promise to transform drug discovery, clinical development and diagnostics in the R&D process. This dynamic market, poised to reach a value of $33.3 billion by 2015, will continue to improve decision-making, clinical trial success rates and translational productivity.

 Drawing on advances in genomics, proteomics and next-generation sequencing, SMi’s 6th annual Biomarkers Summit brings you the latest developments in this exciting field. From compound screening and toxicity testing to companion diagnostic assays, stay competitive with fresh insights from companies at the cutting edge of biopharmaceutical development. You cannot afford to miss this event

Reasons to attend this exciting event include:

Accelerate companion diagnostics development for therapeutic indications

·         Validate and deliver biomarkers for patient selection during clinical trials

·         Implement sub-grouping in patient segmentation studies

·         Utilise revised FDA regulatory guidelines to aid product development

·         Optimise reimbursement strategies for diagnostics

·         Maximise biomarker identification using epigenetic and metabolomic insights


ntContact Farhaana Rahman on tel +44 (0)20 7827 6186 or email: frahman@smi-online.co.uk






SMi Group